Testing effectiveness (Phase 2)Ended earlyNCT02419469
What this trial is testing
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Who this might be right for
LeukemiaPrecursor-B Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma+1 more
M.D. Anderson Cancer Center 1